Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 1/26/2026 | $100.00 | Overweight | Analyst | |
| 1/6/2026 | $13.00 | Market Perform → Outperform | Leerink Partners | |
| 11/21/2025 | $10.00 | Buy | Rothschild & Co Redburn | |
| 11/13/2025 | $9.00 | Market Perform | BMO Capital Markets | |
| 9/29/2025 | $16.00 | Buy | Craig Hallum | |
| 9/15/2025 | $29.00 | Neutral → Underperform | Mizuho | |
| 7/15/2025 | Mkt Perform → Underperform | Raymond James | ||
| 7/3/2025 | $16.00 | Equal-Weight | Morgan Stanley |
8-K - CVR ENERGY INC (0001376139) (Filer)
8-K - EXPONENT INC (0000851520) (Filer)
8-K - CVR ENERGY INC (0001376139) (Filer)
Analyst initiated coverage of Exponent with a rating of Overweight and set a new price target of $100.00
Leerink Partners upgraded Certara from Market Perform to Outperform and set a new price target of $13.00
Rothschild & Co Redburn initiated coverage of Certara with a rating of Buy and set a new price target of $10.00
MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO) today reported financial results for the fourth quarter and fiscal year 2025 ended January 2, 2026. "We delivered a strong finish to 2025 reflecting the strength, diversification, and resilience of our portfolio," stated Dr. Catherine Corrigan, President and Chief Executive Officer. "Growth in proactive engagements during the fourth quarter was driven by increased demand for user research services in the consumer electronics sector and expanded risk management work within utilities. Growth in reactive engagements was led by failure analysis and dispute-related activities across a broad range of sectors, inc
MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO) today announced that its Board of Directors has raised its quarterly cash dividend from $0.30 to $0.31 per share of common stock. The quarterly cash dividend of $0.31 per share of common stock is to be paid on March 20, 2026 to all common stockholders of record as of March 6, 2026. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent's Board of Directors. "The increase in our regular quarte
CVR Energy, Inc. (NYSE:CVI) plans to release its fourth quarter and full-year 2025 earnings results on Wednesday, February 18, after the close of trading on the New York Stock Exchange. The Company also will host a teleconference call on Thursday, February 19, at 1 p.m. Eastern to discuss these results. This call, which will contain forward-looking information, will be webcast live and can be accessed on the Investor Relations section of CVR Energy's website at www.CVREnergy.com. For investors or analysts who want to participate during the call, the dial-in number is (800) 715-9871, conference ID 3388257. A repeat of the call can be accessed for seven days by dialing (800) 770-2030, confe
4 - EXPONENT INC (0000851520) (Issuer)
3 - CVR ENERGY INC (0001376139) (Issuer)
4 - EXPONENT INC (0000851520) (Issuer)
4 - Certara, Inc. (0001827090) (Issuer)
4 - CVR ENERGY INC (0001376139) (Issuer)
4 - CVR ENERGY INC (0001376139) (Issuer)
Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial growth William Feehery to step down as CEO on December 31, 2025 Company reaffirms full year 2025 financial outlook RADNOR, Pa., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, announced today that it has appointed Jon Resnick as its next Chief Executive Officer and member of Certara's Board of Directors, effective January 1, 2026, succeeding William F. Feehery, who will at that point serve as an external advisor during a transition period. Resnick brings over 20 years of experience with IQVIA, a g
RADNOR, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced the appointment of Christopher Bouton, Ph.D., as Chief Technology Officer. In this role, Bouton will lead technology strategy and development of a next-generation integrated model-informed drug development (MIDD) platform, which is enabled by generative AI and advances in biosimulation technology. Dr. Bouton was the founder and CEO of Vyasa Analytics, acquired by Certara in 2022. Vyasa provided scalable deep-learning software, which allows Certara software to make new predictions and answer complex questions across structured and unstructured data
RADNOR, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced the appointment of Adrian McKemey, Ph.D. as President of Drug Development Solutions, effective March 3rd, 2025. In this role, McKemey will lead Certara's global team of drug development scientists. Adrian joins Certara after serving as head of Enterprise Transformation at IQVIA and Senior Vice President and Head of the R&D Strategy Solutions at Quintiles. He has over 25 years of experience in research and development roles where he focused on business transformation, portfolio management and R&D strategies. Before IQVIA, he was a Principal with t
MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO) today reported financial results for the fourth quarter and fiscal year 2025 ended January 2, 2026. "We delivered a strong finish to 2025 reflecting the strength, diversification, and resilience of our portfolio," stated Dr. Catherine Corrigan, President and Chief Executive Officer. "Growth in proactive engagements during the fourth quarter was driven by increased demand for user research services in the consumer electronics sector and expanded risk management work within utilities. Growth in reactive engagements was led by failure analysis and dispute-related activities across a broad range of sectors, inc
MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO) today announced that its Board of Directors has raised its quarterly cash dividend from $0.30 to $0.31 per share of common stock. The quarterly cash dividend of $0.31 per share of common stock is to be paid on March 20, 2026 to all common stockholders of record as of March 6, 2026. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent's Board of Directors. "The increase in our regular quarte
CVR Energy, Inc. (NYSE:CVI) plans to release its fourth quarter and full-year 2025 earnings results on Wednesday, February 18, after the close of trading on the New York Stock Exchange. The Company also will host a teleconference call on Thursday, February 19, at 1 p.m. Eastern to discuss these results. This call, which will contain forward-looking information, will be webcast live and can be accessed on the Investor Relations section of CVR Energy's website at www.CVREnergy.com. For investors or analysts who want to participate during the call, the dial-in number is (800) 715-9871, conference ID 3388257. A repeat of the call can be accessed for seven days by dialing (800) 770-2030, confe
SC 13D/A - CVR ENERGY INC (0001376139) (Subject)
SC 13G - Certara, Inc. (0001827090) (Subject)
SC 13D/A - CVR ENERGY INC (0001376139) (Subject)